Medicine & Life Sciences
Metformin
100%
Type 2 Diabetes Mellitus
87%
Health Care Outcome Assessment
66%
Life Style
47%
Glucose Intolerance
42%
Volunteers
37%
Cardiovascular Diseases
28%
Population
26%
Diabetes Complications
22%
Gestational Diabetes
21%
Risk Reduction Behavior
19%
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
19%
Placebos
18%
Controlled Clinical Trials
17%
Clinical Trials
12%
Minority Groups
12%
Therapeutics
11%
Vulnerable Populations
9%
Public Health
9%
Islets of Langerhans
9%
Hispanic Americans
9%
Mental Competency
9%
Morbidity
8%
African Americans
8%
Hyperglycemia
8%
Atherosclerosis
8%
Insulin Resistance
7%
Mortality
7%
Economics
7%
Weight Loss
7%
B-Lymphocytes
7%
Outpatients
7%
Data Analysis
7%
Blood Vessels
6%
Medicine
6%
Occupational Groups
6%
Research Personnel
6%
Diet
6%
Exercise
6%
Hypertension
6%
Glucose
5%
Hemoglobins
5%
Costs and Cost Analysis
5%